InspireMD Financial Statements From 2010 to 2024
| NSPR Stock | USD 2.09 0.05 2.34% |
Gross Profit 1.1 M | Market Capitalization 50.2 M | Enterprise Value Revenue 2.7383 | Revenue 6.2 M | Earnings Share (0.82) |
InspireMD Total Revenue |
|
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD main balance sheet or income statement drivers, such as Interest Expense of 23.9 K, Selling General Administrative of 8 M or Other Operating Expenses of 16 M, as well as many exotic indicators such as Price To Sales Ratio of 10.44, Dividend Yield of 0.0 or PTB Ratio of 1.81. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
InspireMD | Select Account or Indicator |
InspireMD Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
InspireMD Fundamental Market Drivers
| Forward Price Earnings | 11.6959 | |
| Cash And Short Term Investments | 39 M |
InspireMD Upcoming Events
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
About InspireMD Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include InspireMD income statement, its balance sheet, and the statement of cash flows. InspireMD investors use historical funamental indicators, such as InspireMD's revenue or net income, to determine how well the company is positioned to perform in the future. Although InspireMD investors may use each financial statement separately, they are all related. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on InspireMD's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on InspireMD Financial Statements. Understanding these patterns can help to make the right decision on long term investment in InspireMD. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 18 K | 17.1 K | |
| Total Revenue | 6.2 M | 3.3 M | |
| Cost Of Revenue | 4.4 M | 3.1 M | |
| Stock Based Compensation To Revenue | 0.72 | 0.83 | |
| Sales General And Administrative To Revenue | 1.79 | 2.31 | |
| Research And Ddevelopement To Revenue | 1.29 | 0.86 | |
| Capex To Revenue | (0.06) | (0.06) | |
| Revenue Per Share | 0.26 | 0.24 | |
| Ebit Per Revenue | (3.37) | (3.53) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of InspireMD Correlation against competitors. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.